Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keisuke Miyake

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
BMC Cancer|July 9, 2016
Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature reviewKazuto Harada, Yoshifumi Baba, Hironobu Shigaki, et al.
Medical Oncology (Northwood, London, England)|March 2, 2016
KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature reviewLei Zhou, Yoshifumi Baba, Yuki Kitano, et al.
Medical Oncology (Northwood, London, England)|March 19, 2015
Relationship between LINE-1 hypomethylation and Helicobacter pylori infection in gastric mucosaeKeisuke Kosumi, Yoshifumi Baba, Takatsugu Ishimoto, et al.
Medical Oncology (Northwood, London, England)|April 30, 2015
Cancer-associated fibroblast-derived CXCL12 causes tumor progression in adenocarcinoma of the esophagogastric junctionHidetaka Sugihara, Takatsugu Ishimoto, Tadahito Yasuda, et al.
Oncogene|September 26, 2018
Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreasKota Arima, Masaki Ohmuraya, Keisuke Miyake, et al.
Oncotarget|March 3, 2016
Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinomaRyuma Tokunaga, Yu Imamura, Kenichi Nakamura, et al.
Annals of Nuclear Medicine|August 18, 2021
Determining the extent of tumor resection at surgical planning with <sup>18</sup>F-fluciclovine PET/CT in patients with suspected glioma: multicenter phase III trialsToshihiko Wakabayashi, Yuichi Hirose, Keisuke Miyake, et al.
Cancer Research|July 2, 2020
Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug ResistanceTomoyuki Uchihara, Keisuke Miyake, Atsuko Yonemura, et al.
The Journal of Pathology|May 15, 2018
Impact of loss-of-function mutations at the RNF43 locus on colorectal cancer development and progressionTsugio Eto, Keisuke Miyake, Katsuhiko Nosho, et al.
International Journal of Cancer|September 29, 2015
CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancerDaisuke Izumi, Takatsugu Ishimoto, Keisuke Miyake, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
BMC Cancer|July 9, 2016
Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature reviewKazuto Harada, Yoshifumi Baba, Hironobu Shigaki, et al.
Medical Oncology (Northwood, London, England)|March 2, 2016
KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature reviewLei Zhou, Yoshifumi Baba, Yuki Kitano, et al.
Medical Oncology (Northwood, London, England)|March 19, 2015
Relationship between LINE-1 hypomethylation and Helicobacter pylori infection in gastric mucosaeKeisuke Kosumi, Yoshifumi Baba, Takatsugu Ishimoto, et al.
Medical Oncology (Northwood, London, England)|April 30, 2015
Cancer-associated fibroblast-derived CXCL12 causes tumor progression in adenocarcinoma of the esophagogastric junctionHidetaka Sugihara, Takatsugu Ishimoto, Tadahito Yasuda, et al.
Oncogene|September 26, 2018
Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreasKota Arima, Masaki Ohmuraya, Keisuke Miyake, et al.
Oncotarget|March 3, 2016
Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinomaRyuma Tokunaga, Yu Imamura, Kenichi Nakamura, et al.
Annals of Nuclear Medicine|August 18, 2021
Determining the extent of tumor resection at surgical planning with <sup>18</sup>F-fluciclovine PET/CT in patients with suspected glioma: multicenter phase III trialsToshihiko Wakabayashi, Yuichi Hirose, Keisuke Miyake, et al.
Cancer Research|July 2, 2020
Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug ResistanceTomoyuki Uchihara, Keisuke Miyake, Atsuko Yonemura, et al.
The Journal of Pathology|May 15, 2018
Impact of loss-of-function mutations at the RNF43 locus on colorectal cancer development and progressionTsugio Eto, Keisuke Miyake, Katsuhiko Nosho, et al.
International Journal of Cancer|September 29, 2015
CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancerDaisuke Izumi, Takatsugu Ishimoto, Keisuke Miyake, et al.
Pageof 17